Certain high-risk patients are excluded by current guidelines which could be complemented by including personalized fat z-scores LINKÖPING, Sweden, March 14, 2024…
Medical Research
AMRA Medical Introduces Personalized Z-Scores for Weight Invariant Fat Distribution Assessment
A new method for treatment differentiation beyond weight loss LINKÖPING, Sweden, March 11, 2024 – AMRA researchers together with authors from Linköping…
AMRA Medical at AASLD The Liver Meeting® Showcases MRI-Based Technology and Muscle Biomarkers Linked to Liver Disease Severity and Progression
LINKÖPING, Sweden, November 9, 2023 – AMRA Medical has a large presence at this year’s The Liver Meeting®. A total of nine abstracts…
AMRA Medical’s MRI-based Biomarkers Validated in the FNIH’s NIMBLE Study
LINKÖPING, Sweden, October 25, 2023 – Visceral fat, also known as Visceral Adipose Tissue (VAT), is the adipose tissue inside the abdominal…
AMRA Used in Tirzepatide Analyses Evaluating the Effect on Muscle Composition via MRI
LINKÖPING, Sweden, October 3, 2023 – Two analyses have shed light on an important factor when evaluating treatments that significantly reduce bodyweight:…
AMRA Medical´s latest research finds a strong association between personalized body Fat Z-Scores describing skewed fat distribution and specific Cardiometabolic Risk Profiles
LINKÖPING, Sweden, June 28, 2023 – AMRA researchers together with Linköping University used personalized imaging-derived obesity phenotypes, based on a large, population-based…